KRYS — Krystal Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapHigh Flyer

Annual balance sheet for Krystal Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	194	271	438	379	532
Net Total Accounts Receivable
Net Total Receivables	—	—	—	—	42
Total Inventory
Prepaid Expenses
Total Current Assets	196	275	442	384	588
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11.2	34.2	120	170	168
Long Term Investments
Other Long Term Assets
Total Assets	209	311	626	558	818
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.33	15.5	25.7	28.8	33.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6.11	18.8	32.7	36.2	39.7
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	203	292	594	522	779
Total Liabilities & Shareholders' Equity	209	311	626	558	818
Total Common Shares Outstanding